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Risk factors associated with aortic calcification in  
hemodialysis patients 
 
Abstract 
Background: There are some uncertainties among the risk factors of vascular calcification 
in the hemodialysis patients. This study was planned to examine the association between 
abdominal aortic calcification and concerned biochemical parameters in hemodialysis 
patients. 
Methods: In this cross- sectional study, 84 stable hemodialysis patients admitted on 
hemodialysis section of Shahid Beheshti Hospital in 2013 were enrolled after obtaining 
informed consent. Pre-dialysis venous blood samples were taken from patients to 
determine the amount of intact parathyroid hormone (iPTH), alkaline phosphatase (Alk.P), 
C - reactive protein (CRP), calcium (Ca) and phosphorus (P). Patients underwent 
abdominal CT scanning and ACI (ACI) was calculated. Statistical analysis was performed 
using SPSS Version 20. Chi-square, Kruskal Wallis and One Way ANOVA tests were 
used. P-values < 0.05 were considered significant. 
Results: The average age of participants was 50.15±17.03 years (18-83 y/o).A statistically 
significant correlation was observed between ACI and ALK-P serum levels (p=0.01). It 
was found that ACI had a significant relationship with phosphorus in women (p=0.01). 
ALK-P serum levels in men also had a significant relationship with ACI (p=0.02). In 
addition, there was a significant correlation between ACI and history of cerebro-
cardiovascular disease and also duration of dialysis (p=0.004 and 0.0001, respectively). 
Conclusions: In patients with longer duration of dialysis, and patients with a history of 
cardiovascular and cerebrovascular events, ACI levels were significantly higher. ALK-P 
and phosphorus were correlated with aortic calcification in males and females respectively. 
No significant correlation was found between iPTH serum levels and aortic calcification. 
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Cardiovascular disease (CVD) and stroke are the main causes of morbidity and 
mortality in end-stage renal disease (ESRD). The risk of CVD in ESRD is about 10-20 
times more than the normal population (1). The range of vascular changes in patients with 
ESRD is studied from three aspects: the atheromatous plaques by intima media thickness 
(IMT), sclerosis and vascular stiffness (compliance reduction) with pulse wave velocity 
(PWV) and vascular calcification by lateral abdominal radiography or axial CT (2). There 
are two types of arterial calcification: atherosclerotic lesions with calcium deposits in 
intimal layer which is associated with fat accumulation, macrophage infiltration and 
fibrous tissue (3) and medial calcification or Monckeberg that is not common in ordinary 
people and is usually seen in diabetic or uremic patients. Medial calcification reduces 
vascular compliance and affects the blood pressure and induces stress on the myocardium 
and major vessels (4). 
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On the other hand, secondary hyperparathyroidism 
occurs at the early stages of kidney failure and can affect 
other organs such as soft tissues and the bones (5). The 
relationship between the parathyroid hormone (PTH) 
secretion disorder and cardiovascular calcification is 
completely unclear and no clinical studies has systematically 
checked the parathyroidectomy effect on vascular 
calcification (5), and it seems that mortality is increased at 
very high PTH levels (6). In general, it seems that both the 
upper and lower limits of PTH level can induce vascular 
calcification. Due to the uncertainty about many risk factors 
for abdominal aortic calcification, this study was done in the 
hemodialysis patients. 
 
 
Methods 
In this cross-sectional study, 84 out of all hemodialysis 
patients admitted to the Shahid Beheshti hospital in 2013 
who had the inclusion criteria were included after obtaining 
written consent. This study was approved by the Ethics 
Committee of the Babol University of Medical Sciences. 
Exclusion criteria were acute infection, known malignancy, 
active vascular collagen diseases such as rheumatoid arthritis 
and intake of phosphate binders like sevelamer or aluminum 
hydroxide during the tests (in cases where the patient used 
these drugs, it should had been stopped at least a month 
before the entry into the plan), duration of dialysis less than 
3 months, diabetes, being under oral anticoagulant therapy 
and having a history of parathyroidectomy. Calcium 
carbonate was continued and because of short term 
discontinuation of phosphate binders, there was no ethical 
issue. History of cardiovascular or cerebrovascular events 
was collected based on history and medical records.  Patients 
were dialyzed with low flux polysulphone dialysers and 
dialysate calcium of 1.5 mmol / L 3 times a week, each time 
for 4 hours. Online Kt/V of all patients were over 1.1 .Blood 
samples of 5cc were taken from patients in the morning 
before dialysis in the tube containing EDTA anticoagulant to 
determine the amount of iPTH, CRP, P, Ca and ALK-P. All 
subjects were fasting and all experiments were performed at 
the hospital.  
Blood samples were poured in a dry tube and centrifuged 
for 10 minutes in 1000cycle/min, the serum was separated 
and kept at -70°C. All samples were analyzed 
simultaneously. All patients underwent axial CT scan 
without contrast on the abdominal aorta. The CT scanner 
was a multi-slice – 16 (Siemens). Aortic calcification index 
(ACI) measurement was as following: CT scan without 
contrast was taken in 10 sections from abdominal aorta 
between the place of separation of kidney arteries and the 
bifurcation of abdominal aorta. Each cross section of the 
aorta was divided into 12 sectors (fig. 1). The sectors in 
which calcification (with HU more than 100) were seen were 
counted and then the sum was calculated to obtain ACI score 
for each patient. ACI of patients was analyzed by a 
professional radiologist blinded about the patients.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. ACI measurement (score 6/12 in this cut) 
 
CT scans and measurement of biochemical indices per 
person was almost simultaneously done. ACI of patients was 
divided into three groups: 0-40, 41-80 and 81-120 (sectors) . 
To collect information, first a checklist including age, 
gender, biochemical factors, ACI and the duration of dialysis 
and history of cardiovascular diseases in patients were 
collected. Statistical analysis was performed using SPSS 
Version. 20.  
Quantitative variables were shown as mean ± SD. The 
Kolmogorov-Smirnov test was used to evaluate the 
normality of distribution of quantitative data. Chi-square test 
was used to compare the ACI with respect to gender, 
duration of dialysis, and history of cardiovascular disease. 
To investigate the relationship between ACI and other 
chemical factors, Kruskal Wallis test for nonparametric 
variables and One Way ANOVA for analysis of variables 
with normal distribution were used. A p-value less than 0.05 
was considered significant. 
 
 
Results 
A total of 84 patients were studied. The average age of 
participants was 50.15±17.03 years (range of 18-83 years). 
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46 (54.8%) were men and 38 (45.2%) were women. 29 
(34.5%) patients were on chronic dialysis less than 3 years 
and 55 (65.5%) patients for more than 3 years. 44 (52.4%) 
had no history of cardiovascular events and 40 (47.6%) had a 
history of cardiovascular or cerebrovascular events. The 
average of paraclinical parameters were: calcium (8.67+0.97 
mg/dl), phosphorous (4.04+1.37 mg/dl) with normal 
distribution but alkaline phosphates (median 350 U/L), intact 
PTH (median 322 Pg/ml) and C-reactive protein (median 
5.50 mg/L) with abnormal distribution.  Most of patients 
with a frequency of 44 (52.4%) cases had an ACI score 
between 0-40 (fig 2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Frequency percentage of ACI different values 
 
As seen in table 1, two variables (duration of dialysis and 
history of cardiovascular events, and strokes) had a 
significant relationship with ACI. But this relationship was 
not seen with gender.  
Table 2 shows the relationship between the ACI and the 
duration of dialysis and a history of vascular events based on 
gender. 
Table 1. Relationship between ACI and gender, duration 
of dialysis, and history of vascular events 
Variable ACI score P-value* 
 0-40 
N(%) 
41-80 
N(%) 
81-120 
N(%) 
Gender 
Male 
Female 
 
25(54.3) 
19(50.0) 
 
14(30.4) 
11(28.9) 
 
7(15.2) 
8(21.1) 
 
0.78 
Duration of 
dialysis 
< 3 years 
> 3 years 
 
 
23(79.3) 
21(38.2) 
 
 
3 (10.3) 
22(40.0) 
 
 
3(10.3) 
12(21.8) 
 
 
0.001 
History of 
vascular events 
Yes 
No 
 
 
5 (12.5) 
39(88.6) 
 
 
20(50.0) 
5 (11.4) 
 
 
15(37.5) 
- 
 
 
<0.0001 
*P-value, chi-square test 
Except for duration of dialysis in women, a significant 
association was seen with other parameters. Examining the 
relationship between ACI and serum biochemical factors, 
statistically significant correlation was observed between 
ACI and ALK-P (p=0.01) (table 3).  
Regarding the relationship between the ACI amount and 
biochemical in men and women, it was found that P factor in 
women has a significant relationship with ACI (p=0.01). 
ALK-P in men also had a significant relationship with ACI 
(p=0.02). 
 The results of the relationship between ACI and 
biochemical factors are shown in details in table 4. No 
significant relationship was observed between ACI and 
serum biochemical factors based on dialysis duration  
(table 5). 
 
Table 2. Relationship between ACI score in the duration of dialysis and history of coronary events based on gender 
Gender 
 
ACI score 
P-value* 0-40 
N(%) 
41-80 
N(%) 
81-120 
N(%) 
Male 
Duration 
of dialysis 
< 3 years 
> 3 years 
17 (%77.3) 
8 (%33.3) 
2 (%9.1) 
12 (%50.0) 
3 (%13.6) 
4 (%16.7) 
0.004 
Female 
< 3 years 
> 3 years 
6 (%85.7) 
13 (%41.9) 
1 (%14.3) 
10 (%32.3) 
- 
8 (%25.8) 
0.11 
Male  history of 
vascular 
events 
Yes 
No 
4 (%16.7) 
21 (%95.5) 
13 (%54.2) 
1 (%4.5) 
7 (%29.2) 
- 
< 0.0001 
Female 
Yes 
No 
1 (%6.3) 
18 (%81.8) 
7 (%43.8) 
4 (%18.2) 
8 (%50.0) 
- 
< 0.0001 
*P-value, Chi-square test 
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Table 3. Relationship between ACI score and serum biochemical parameters 
Biochemical factors 
ACI score 
P-value* 
0-40 41-80 81-120 
Calcium (mg/dl) (mean±SD) 8.57±0.83 8.82±1.16 8.81±1.05 0.50 
Phosphorus(mg/dl) (mean±SD) 3.86±1.51 4.42±1.19 3.94±1.13 0.06 
Alkaline phosphatase(U/L) 
median(MIN-MAX 
300 (38-2630) 331 (166-1534) 520 (210-1450) 
0.01 
iPTH( pg/ml) median(MIN-MAX) 280 (16-1269) 339 (67-870) 360 (69-1389) 0.16 
CRP(mg/L) median(MIN-MAX) 3 (2-86) 12 (2-68) 11.5 (2-83) 0.33 
*P-value, One – way ANOVA test 
 
Table 4. Relationship between biochemical parameters and ACI based on gender 
Variable Gender 
ACI score 
P-value* 
0-40 41-80 81-120 
Ca(mg/dl)  
(mean±SD) 
Male 8.44±0.90 8.78±1.46 8.55±1.15 0.66 
Female 8.74±0.70 8.88±0.68 9.03±0.97 0.64 
P(mg/dl) 
(mean±SD) 
Male 4.16±1.69 4.32±1.38 4.10±1.30 0.84 
Female 3.48±1.18 4.54±0.93 3.80±1.04 0.01 
iPTH( pg/ml) 
median(min-max) 
Male 284(16-1269) 381.5(67-772) 360(190-507) 0.54 
Female 261(28-665) 327(125-870) 455.5(69-1389) 0.27 
Alk.P(U/L) 
median(min-max) 
Male 298(68-2630) 287(166-892) 540(391-698) 0.02 
Female 314(38-753) 450(226-1534) 478(210-1450) 0.17 
CRP(mg/L) 
median(min-max) 
Male 6 (2-78) 15.5 (2-55) 15 (2-71) 0.21 
Female 2 (2-86) 2 (2-68) 7 (2-83) 0.75 
*P-value,  Kruskal Wallis test 
 
Table 5. Relationship between biochemical factors and ACI score based on dialysis duration 
Variables 
Dialysis 
duration 
ACI score 
P value 
0-40 41-80 81-120 
Ca(mg/dl) 
(mean±SD) 
< 3 years 8.48±0.93 8.20±1.05 8.10±1.05 0.73* 
> 3years 8.66±0.71 8.91±1.17 8.99±1.02 0.58* 
P(mg/dl) 
(mean±SD) 
< 3years 3.63±1.31 3.70±0.17 3.56±1.00 0.79* 
> 3years 4.11±1.71 4.52±1.23 4.03±1.19 0.26* 
iPTH( pg/ml) 
median(min-max) 
< 3years 199 (28-1269) 320 (305-403) 317 (280-376) 0.65** 
> 3years 284 (16-1038) 353 (67-870) 381.5 (69-1389) 0.23** 
Alk.P(U/L) 
median(min-max) 
< 3years 294 (68-2630) 318 (266-549) 540 (488-541) 0.08** 
> 3years 343 (38-753) 366 (166-1534) 500 (210-1450) 0.23** 
CRP(mg/L) 
median(min-max) 
< 3years 6 (2-86) 2 (2-42) 15 (2-28) 0.74** 
> 3years 2 (2-86) 13 (2-68) 11.5 (2-83) 0.52** 
*P-value : One way ANOVA test                 **P-value : Kruskal Wallis test 
 
Discussion 
In this study, the relationship between abdominal ACI 
and biochemical parameters, duration of dialysis, 
cardiovascular events or stroke and gender in chronic 
hemodialysis patients were studied. ACI in 40% of patients  
 
 
who were under dialysis for more than 3 years, was in the 
range of 41-80, while around 10% of patients with dialysis 
for less than 3 years, had a 41-80 ACI. Futhermore, the 
percentage of the ACI  in 81-120 was higher in hemodialysis 
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patients with over 3 years than dialysis patients with less 
than 3 years, and the relationship was statistically significant. 
On the other hand, the patients with a history of 
cardiovascular events had bigger ACI than patients with no 
history of the disease. So, 37.5% of patients with a history of 
cardiovascular events had the ACI between 81-120, but none 
of the patients with no history of cardiovascular events had 
the ACI between 81-120.  
With regard to gender, ACI in men was associated with 
duration of dialysis, but this relationship was not seen in 
women. 50% of men, who were under dialysis for more than 
3 years, had the ACI between 41-80. In the case of history of 
coronary events, a highly significant correlation was 
observed with the ACI in men and women. In this study, 
ACI and mean alkaline phosphatase show a statistically 
significant relationship. In females, the group with ACI in 
the range of 41-80 has the highest phosphorus While the ACI 
in men in the range of 81-120 has the highest alkaline 
phosphatase. 
First, we examined the level of the ACI in patients with 
dialysis duration of less than 3 years. It was observed that in 
patients with a longer history of dialysis, the ACI level was 
significantly higher. This may be a result of long 
hyperparathyroidism and the consequence of the destruction 
of the vessels. In studies by Litwin (2005), Goodman (2000), 
and Oh (2002), it was also found that vascular damage was 
more in patients with longer duration of dialysis (7-9). In a 
study by Block et al., (2005), it was concluded that vascular 
calcification occured in 65% of adult patients with chronic 
kidney disease who started dialysis. This trend increases 
with increasing duration of dialysis (10). Finally, the 
findings of this study are consistent with the results of the 
above studies. 
Next step, we studied the level of the ACI in patients 
with and without a history of cardiovascular events. The 
results showed that a higher level of ACI was observed in 
patients with vascular events and this difference was 
statistically significant. In studies done before, the 
relationship between ACI and cardiovascular events were 
never directly and independently investigated. But 
previously, it was seen that on the one hand in chronic 
hemodialysis patients with positive history of vascular 
events, the carotid intima-media thickness (CIMT) is also 
higher (11, 12) while a positive strong relationship was seen 
between CIMT and ACI (2, 13). By summing up these 
results, a relationship between ACI and vascular events was 
shown definitely in our study, it appears for the first time 
that such a relationship was directly and independently 
sought and as expected, a strong positive correlation was 
also found. The study examined the association between ACI 
and biochemical factors such as calcium, phosphorus, 
parathoromone, alkaline phosphatase and C - reactive 
protein. We found that ACI is associated with alkaline 
phosphatase. Then, the relationship between ACI and 
biochemical factors such as calcium, phosphorus, PTH, 
alkaline phosphatase and C - reactive protein based on 
gender was examined. 
Several studies showed that the high alkaline phosphatase 
is a strong risk factor for cardiovascular and non-
cardiovascular mortality in dialysis patients (14). In a study 
by Regidor et al., it was found that patients with alkaline 
phosphatase more than 120 U/L was associated with a 
mortality rate increased of 1.25 times (15). Beddhu et al., 
also found that higher alkaline phosphatase, independent of 
bone metabolism parameters and liver enzymes, increases 
mortality in hemodialysis patients. (16) Compared to ACI 
and ALK-P according to gender, a significant relationship 
was observed between ACI and ALK-P in men, but we did 
not find a reason to this relationship. When the association 
between ACI and P was analyzed based on gender, a 
relationship was found between these two parameters in 
female patients that did not exist in men . No logical 
explanation was found for this difference .In the above 2 
cases, it could not be explained and justified, including other 
parameters such as underlying diseases, socioeconomic 
status and habits of patients though their ability for regular 
and timely follow-up of treatment may help. 
In conclusions patients with longer duration of dialysis, 
and patients with a history of cardiovascular events and 
stroke, ACI level was significantly higher. There is a strong 
relationship between Alkaline phosphatase level and ACI in 
men and between phosphorus and ACI in women. 
The limitations and strengths of this study: As far as our 
search is concerned, there are few studies in which the 
relationship between ACI index on the one hand and 
biochemical factors, the duration of dialysis and history of 
vascular events on the other hand have been studied. It 
seems that ACI can be used as a useful indicator to predict 
the occurrence of vascular events in ESRD patients. The 
method used in this study for ACI categorization (0-40, 41-
80, 81-120) in ESRD patients has been used just one time in 
Japan (2) and repeated here now. Healthy people in the ACI 
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categorization method which was used in this study had not 
been investigated. Consequently, actually there was no 
control group against case group (ESRD patients). 
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